Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation
Michelle Zuo, Naomi M. Fettig, Louis-Philippe Bernier, Elisabeth Pössnecker, Shoshana Spring, Annie Pu, Xianjie I. Ma, Dennis S.W. Lee, Lesley A. Ward, Anshu Sharma, Jens Kuhle, John G. Sled, Anne-Katrin Pröbstel, Brian A. MacVicar, Lisa C. Osborne, Jennifer L. Gommerman, Valeria Ramaglia
Michelle Zuo, Naomi M. Fettig, Louis-Philippe Bernier, Elisabeth Pössnecker, Shoshana Spring, Annie Pu, Xianjie I. Ma, Dennis S.W. Lee, Lesley A. Ward, Anshu Sharma, Jens Kuhle, John G. Sled, Anne-Katrin Pröbstel, Brian A. MacVicar, Lisa C. Osborne, Jennifer L. Gommerman, Valeria Ramaglia
View: Text | PDF | Erratum
Research Article Immunology

Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation

  • Text
  • PDF
Abstract

People living with multiple sclerosis (MS) experience episodic CNS white matter lesions instigated by autoreactive T cells. With age, patients with MS show evidence of gray matter demyelination and experience devastating nonremitting symptomology. What drives progression is unclear and studying this has been hampered by the lack of suitable animal models. Here, we show that passive experimental autoimmune encephalomyelitis (EAE) induced by an adoptive transfer of young Th17 cells induced a nonremitting clinical phenotype that was associated with persistent leptomeningeal inflammation and cortical pathology in old, but not young, SJL/J mice. Although the quantity and quality of T cells did not differ in the brains of old versus young EAE mice, an increase in neutrophils and a decrease in B cells were observed in the brains of old mice. Neutrophils were also found in the leptomeninges of a subset of progressive MS patient brains that showed evidence of leptomeningeal inflammation and subpial cortical demyelination. Taken together, our data show that while Th17 cells initiate CNS inflammation, subsequent clinical symptoms and gray matter pathology are dictated by age and associated with other immune cells, such as neutrophils.

Authors

Michelle Zuo, Naomi M. Fettig, Louis-Philippe Bernier, Elisabeth Pössnecker, Shoshana Spring, Annie Pu, Xianjie I. Ma, Dennis S.W. Lee, Lesley A. Ward, Anshu Sharma, Jens Kuhle, John G. Sled, Anne-Katrin Pröbstel, Brian A. MacVicar, Lisa C. Osborne, Jennifer L. Gommerman, Valeria Ramaglia

×

Figure 4

Aging induces accumulation of NfL in SJL/J A/T EAE mice and loss of brain volume at the postacute disease stage.

Options: View larger image (or click on image) Download as PowerPoint
Aging induces accumulation of NfL in SJL/J A/T EAE mice and loss of brai...
(A) Serum neurofilament light chain (NfL) levels in young (n = 4–12) and old (n = 4–7) SJL/J A/T EAE mice at the acute (day 11) and postacute (day 25) disease stages. Age-matched, unimmunized controls included for comparison at the postacute time point (young, n = 4; old, n = 4). (B) Correlation analysis of clinical severity represented by AUC with levels of serum NfL. (C) Representative images in the somatosensory cortex (SSC) of old versus young SJL/J A/T EAE mice. (D) Quantification of IHC staining for NfL using %NfL+ area. (E) Correlation analysis of NfL immunohistochemistry and serum levels. (F) Clinical course of old (n = 8) versus young (n = 8) SJL/J A/T EAE mice followed for 40 days post-A/T. Statistical analysis by 2-way ANOVA with Bonferroni’s correction for multiple comparisons; error bars indicate mean ± SD. (G) Ex vivo MRI image of an SJL/J A/T EAE mouse showing the axial length of the skull from the nasal cavity (green arrow) to the base of the skull (red arrow). (H) Brain volume of young (n = 3–5) versus old (n = 5–6) SJL/J A/T EAE mice expressed as a ratio to axial length. (I) Percentage change in SJL/J A/T EAE mice from age-matched controls (young n = 3, old n = 3) at acute and postacute disease stages. Statistical analysis by Mann-Whitney U test; error bars indicate mean ± SD. (J) Correlation analysis of clinical severity with brain volume. (K) SSC volume of each mouse expressed as a ratio to axial length. (A, H, and K) Statistical analysis by 1-way ANOVA with Bonferroni’s correction for multiple comparisons; error bars indicate mean ± SD. (D) Statistical analysis by Kruskal-Wallis with correction for multiple comparisons; error bars indicate mean ± SD. (B and E) Statistical analysis by Spearman’s correlation test. (J) Statistical analysis by Pearson’s correlation test. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts